Edwin J. Thomas

Mr. Thomas has over 30 years of C-level executive experience including over 25 years with companies in the biotech and pharmaceutical industries. Prior to founding Eleison in 2009, Mr. Thomas was chief operating officer of Provid Pharmaceuticals, a company engaged in the discovery and development of autoimmune disease therapeutics and remains involved with Provid as a member of its board of directors. Previously, Mr. Thomas was CEO of CMI Inc. a cancer focused biotech company, and was, COO of Avid Therapeutics Inc., an anti-viral drug discovery biotech company, Mr. Thomas received a B.S. degree in biochemistry and economics from the University of Pennsylvania in 1981, and an MBA from The Wharton School in 1984.